L.MachadoM
In the short-term simvastatin stratum, ALC reduced HOMA-IR along with a significant decrease in insulin concentration, suggesting a possible initial metabolic effect of the study drug
For patients who have been tracking the longevity medicine space who understand the difference between reactive disease management and proactive optimization this is a meaningful signal
Some patients experience improved blood pressure control so dramatically that they eventually need only a lower-dose medication or, in rare cases, discontinue one medication entirely
Messages 4,642 Reaction score 12,254 Points 758 Location San Jose Arrma RC's Limitless #17 No, offense, your use of analogies is what gets you pointed in the wrong directions
Tirzepatide Tirzepatide (Mounjaro, Eli Lilly) is a dual incretin agonist that targets both GLP-1 and GIP receptors